<VariationArchive VariationID="619980" VariationName="NM_006516.4(SLC2A1):c.161dup (p.Ser55fs)" VariationType="Duplication" Accession="VCV000619980" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2019-03-19" MostRecentSubmission="2019-03-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="611376" VariationID="619980">
      <GeneList>
        <Gene Symbol="SLC2A1" FullName="solute carrier family 2 member 1" GeneID="6513" HGNC_ID="HGNC:11005" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42925353" stop="42958868" display_start="42925353" display_stop="42958868" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43391045" stop="43424846" display_start="43391045" display_stop="43424846" Strand="-" />
          </Location>
          <OMIM>138140</OMIM>
          <Haploinsufficiency last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006516.4(SLC2A1):c.161dup (p.Ser55fs)</Name>
      <CanonicalSPDI>NC_000001.11:42931159:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42931159" stop="42931160" display_start="42931159" display_stop="42931160" variantLength="1" positionVCF="42931159" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43396830" stop="43396831" display_start="43396830" display_stop="43396831" variantLength="1" positionVCF="43396830" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>S55fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.43396831dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.43396831dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.42931160dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.42931160dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008232.1" sequenceAccession="NG_008232" sequenceVersion="1" change="g.33017dup">
            <Expression>NG_008232.1:g.33017dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006516.4" sequenceAccession="NM_006516" sequenceVersion="4" change="c.161dup" MANESelect="true">
            <Expression>NM_006516.4:c.161dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006507.2" sequenceAccession="NP_006507" sequenceVersion="2" change="p.Ser55fs">
            <Expression>NP_006507.2:p.Ser55fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1132" sequenceAccession="LRG_1132">
            <Expression>LRG_1132:g.33017dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.161dup (p.Ser55fs) AND multiple conditions" Accession="RCV000760180" Version="2">
        <ClassifiedConditionList TraitSetID="26571">
          <ClassifiedCondition DB="MedGen" ID="C1842534">Childhood onset GLUT1 deficiency syndrome 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1832855">Dystonia 9</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551966">Encephalopathy due to GLUT1 deficiency</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3553859">Epilepsy, idiopathic generalized, susceptibility to, 12</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1837206">Hereditary cryohydrocytosis with reduced stomatin</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-03-19" MostRecentSubmission="2019-03-19">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="26571" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1437" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY</ElementValue>
                <XRef Type="MIM" ID="601042" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dystonia 9</ElementValue>
                <XRef ID="MONDO:0010983" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DYT9</ElementValue>
                <XRef Type="MIM" ID="601042" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA</ElementValue>
                <XRef Type="MIM" ID="601042" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16656" />
                <XRef ID="16656" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="53583" DB="Orphanet" />
              <XRef ID="C1832855" DB="MedGen" />
              <XRef ID="MONDO:0010983" DB="MONDO" />
              <XRef Type="MIM" ID="601042" DB="OMIM" />
            </Trait>
            <Trait ID="1929" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">De Vivo disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 1, infantile onset, severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose transporter protein syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Encephalopathy due to GLUT1 deficiency</ElementValue>
                <XRef ID="MONDO:0011724" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose transport defect, blood-brain barrier</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GLUT1DS1</ElementValue>
                <XRef Type="MIM" ID="606777" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9265" />
                <XRef ID="9265" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <XRef ID="71277" DB="Orphanet" />
              <XRef ID="C4551966" DB="MedGen" />
              <XRef ID="MONDO:0011724" DB="MONDO" />
              <XRef Type="MIM" ID="606777" DB="OMIM" />
            </Trait>
            <Trait ID="1930" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystonia 18</ElementValue>
                <XRef ID="Dystonia+18/2414" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal exertion-induced dyskinesia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal exercise-induced dystonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Childhood onset GLUT1 deficiency syndrome 2</ElementValue>
                <XRef ID="MONDO:0012805" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PxMD-SLC2A1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL EXERCISE-INDUCED DYSKINESIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL EXERTION-INDUCED DYSTONIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PED WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT18</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PED</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GLUT1DS2</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10541" />
                <XRef ID="10541" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <XRef ID="98811" DB="Orphanet" />
              <XRef ID="C1842534" DB="MedGen" />
              <XRef ID="MONDO:0012805" DB="MONDO" />
              <XRef Type="MIM" ID="612126" DB="OMIM" />
            </Trait>
            <Trait ID="17407" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epilepsy, idiopathic generalized, susceptibility to, 12</ElementValue>
                <XRef ID="MONDO:0013919" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EIG12</ElementValue>
                <XRef Type="MIM" ID="614847" DB="OMIM" />
              </Symbol>
              <XRef ID="C3553859" DB="MedGen" />
              <XRef ID="MONDO:0013919" DB="MONDO" />
              <XRef Type="MIM" ID="614847" DB="OMIM" />
            </Trait>
            <Trait ID="864" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary cryohydrocytosis with reduced stomatin</ElementValue>
                <XRef ID="MONDO:0012143" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUT1 DEFICIENCY SYNDROME WITH PSEUDOHYPERKALEMIA AND HEMOLYSIS</ElementValue>
                <XRef Type="MIM" ID="608885" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Stomatin-deficient cryohydrocytosis with neurologic defects</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SDCHCN</ElementValue>
                <XRef Type="MIM" ID="608885" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17036" />
                <XRef ID="17036" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="168577" DB="Orphanet" />
              <XRef ID="C1837206" DB="MedGen" />
              <XRef ID="MONDO:0012143" DB="MONDO" />
              <XRef Type="MIM" ID="608885" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1741324" SubmissionDate="2018-10-17" DateLastUpdated="2019-03-19" DateCreated="2019-03-19">
        <ClinVarSubmissionID localKey="15A3945|OMIM:601042;606777;612126;608885;614847" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000890005" DateUpdated="2019-03-19" DateCreated="2019-03-19" Type="SCV" Version="1" SubmitterName="Génétique des Maladies du Développement, Hospices Civils de Lyon" OrgID="506599" OrganizationCategory="laboratory" OrgAbbreviation="HCL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Intellectual Disability NGS Panel (450 genes)</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.2:c.161dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601042" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606777" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612126" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608885" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614847" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Lyon_DI-450_20181017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1741324" TraitType="Disease" MappingType="XRef" MappingValue="608885" MappingRef="OMIM">
        <MedGen CUI="C1837206" Name="Hereditary cryohydrocytosis with reduced stomatin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1741324" TraitType="Disease" MappingType="XRef" MappingValue="606777" MappingRef="OMIM">
        <MedGen CUI="C4551966" Name="Encephalopathy due to GLUT1 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1741324" TraitType="Disease" MappingType="XRef" MappingValue="612126" MappingRef="OMIM">
        <MedGen CUI="C1842534" Name="Childhood onset GLUT1 deficiency syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1741324" TraitType="Disease" MappingType="XRef" MappingValue="614847" MappingRef="OMIM">
        <MedGen CUI="C3553859" Name="Epilepsy, idiopathic generalized, susceptibility to, 12" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1741324" TraitType="Disease" MappingType="XRef" MappingValue="601042" MappingRef="OMIM">
        <MedGen CUI="C1832855" Name="Dystonia 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

